Indication
Musculoskeletal Disorder
1 clinical trial
2 products
Product
AtalurenClinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label ExtensionStatus: Completed, Estimated PCD: 2022-03-05
Product
PLACEBO